Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Varshasb Broumand"'
Autor:
Michael J. Germain, Subir K. Paul, George Fadda, Varshasb Broumand, Andy Nguyen, November H. McGarvey, Matthew D. Gitlin, Charles W. Bishop, Philipp Csomor, Stephen Strugnell, Akhtar Ashfaq
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Introduction Extended-release calcifediol (ERC), active vitamin D hormones and analogs (AVD) and nutritional vitamin D (NVD) are commonly used therapies for treating secondary hyperparathyroidism (SHPT) in adults with stage 3–4 chronic kid
Externí odkaz:
https://doaj.org/article/ea5d7f0a4e0d41f78b22eb2bdd5d89d2
Autor:
November McGarvey, George Z. Fadda, Andy Nguyen, Matthew Gitlin, Michael J. Germain, Akhtar Ashfaq, Charles W. Bishop, Varshasb Broumand
Publikováno v:
American journal of nephrology. 52(10-11)
Introduction: The safety and efficacy of extended-release calcifediol (ERC) as a treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency (VDI) has been demonstrated in pr
Autor:
Michael J. Germain, Subir K Paul, George Fadda, Matthew Gitlin, Akhtar Ashfaq, November McGarvey, Andy Nguyen, Varshasb Broumand
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Extended-release calcifediol (ERC), active vitamin D analogs (VDA), and nutritional vitamin D (NVD) are the predominant vitamin D therapies (VDTs) commonly used for treatment (Tx) of secondary hyperparathyroidism (SHPT) in adults
Publikováno v:
American Journal of Kidney Diseases. 34:768-774
Autor:
Behrooz, Broumand, Alireza Abdollah, Shamshirsaz, Mohammad, Kamgar, Reza, Hashemi, Farzam, Aiazi, Mirreza, Bekheirnia, Navid, Boozary, Zahra, Komeilian, Amir Hooshang Abdollah, Shamshirsaz, Mehdi Rohani, Tabatabaiee, Varshasb, Broumand
Publikováno v:
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 13(4)
Hepatitis C virus (HCV) is the most common cause of chronic liver disease in patients with end-stage renal disease. It is more prevalent in hemodialysis (HD) patients than the general population but the exact routes of transmission are not clear. In
Autor:
Mehrdad Borghei, Farzam Ayazi, Nima Pourzahedgilani, Amir A. Shamshirsaz, M Kamgar, Varshasb Broumand, Niloofar Nobakht Haghighi, Mir Reza Bekheirnia, Alireza A. Shamshirsaz, Behrooz Broumand, Maziyar Moradi, Mohammad Reza Habibzadeh, Navid Bouzari, Seyed Reza Hashemi
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 5, Iss 1, p 13 (2004)
BMC Nephrology, Vol 5, Iss 1, p 13 (2004)
Background Hepatitis C virus (HCV) infection is a significant problem among patients undergoing maintenance hemodialysis (HD). We conducted a prospective multi-center study to evaluate the effect of dialysis machine separation on the spread of HCV in